ERNEXA THERAPEUTICS INC (ERNA) Stock Income Statement
NASDAQ:ERNA - Nasdaq - US1140822099 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 582.00K | 68.00K | 0.00 | 0.00 | 5.80M | |||
| Cost Of Goods | 96.00K | 236.00K | N/A | N/A | 2.91M | |||
| Gross Profit | 486.00K | -168.00K | N/A | N/A | 2.89M | |||
| Operating Expenses | 17.74M | 20.51M | 27.23M | 27.43M | 8.29M | |||
| Research and Development | 4.60M | 5.92M | 10.39M | 12.71M | 2.00M | |||
| Selling, General, and Administrative Expenses | 13.13M | 14.59M | 16.84M | 14.72M | 6.09M | |||
| Operating Income | -17.25M | -20.68M | -27.23M | -27.43M | -5.40M | |||
| Interest Income/Expense | -6.95M | -535.00K | -970.00K | -70.00K | -140.00K | |||
| Other Income/Expense | 550.00K | -1.00K | 9.65M | 660.00K | 2.03M | |||
| Non Recurring Items | -20.86M | -460.00K | -5.99M | -85.99M | -910.00K | |||
| Income Before Taxes | -44.51M | -21.67M | -24.53M | -122.48M | -4.42M | |||
| Income Tax | 30.00K | -3.00K | 50.00K | 60.00K | -10.00K | |||
| Net Income | -44.55M | -21.68M | -24.60M | -122.56M | -4.43M | |||
| EBITDA | -15.61M | -19.55M | -27.07M | -27.31M | -3.66M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.26 | -4.08 | -8.06 | -56.47 | -63.28 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 83.51% | -247.06% | N/A | N/A | 49.83% | |||
| Profit Margin | -7655.50% | -31888.24% | N/A | N/A | -76.38% | |||
| Operating Profit Margin | -2963.92% | -30404.41% | N/A | N/A | -93.10% | |||
All data in USD